Approaches to the development of pharmacological interventions in multiple sclerosis.
D000200:Action Potentials; D001831:Body Temperature; D002118:Calcium / Q000502:physiology; D004553:Electric Conductivity; D006801:Humans; D007473:Ion Channels / Q000502:physiology; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D009186:Myelin Sheath / Q000502:physiology; D009407:Nerve Block; D009413:Nerve Fibers, Myelinated / Q000502:physiology; D009431:Neural Conduction; D010539:Permeability; D011188:Potassium / Q000502:physiology; D012964:Sodium / Q000378:metabolism; D013997:Time Factors
D007473:Ion Channels; D012964:Sodium; D011188:Potassium; D002118:Calcium